Dr. Marie A. Dowling, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 14267 W Bell Rd, Surprise, AZ 85374 Phone: 623-546-5230 |
Carl W Otte, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 20101 N Lagos Ct, Surprise, AZ 85374 Phone: 623-546-9204 |
Jennilyn Joy Puhawan Cave, LAT Emergency Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 14440 W Tierra Buena Ln, Surprise, AZ 85374 Phone: 855-546-1342 |
Linh C Nguyen, M.D., M.S., CPE Emergency Medicine Medicare: Medicare Enrolled Practice Location: 14780 W. Mountain View Blvd., Suite 110, Surprise, AZ 85374 Phone: 623-374-7774 Fax: 623-240-1110 |
Jacob Robert Russell, DO Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 16815 W Bell Rd, Surprise, AZ 85374 Phone: 602-833-6900 |
Mikali Nicole Frans, FNP-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 16575 W Waddell Rd, Surprise, AZ 85388 Phone: 623-300-9110 |
Emma Risk, LAT, ATC Emergency Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 14440 W Tierra Buena Ln, Surprise, AZ 85374 Phone: 855-546-1342 |
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that between December 8, 2010 and February 9, 2011 it entered into agreements with certain accredited investors, pursuant to which the Company sold to the purchasers in the aggregate approximately $7.8 million of the Company's Series D convertible preferred stock, which is convertible into shares of common stock at a conversion price of $0.50 per share.
At NYU Langone Medical Center the focus on quality, patient safety and patient experience are not just broad stroke initiatives - but measurable, quantifiable and concrete. Patients and health care professionals can learn about this commitment to world-class care and operational transparency in the Department of Orthopaedic Surgery's recently published "2012 Quality and Outcomes Report," which is now available online as well as in hard copy at the American Academy of Orthopaedic Surgeons (AAOS) meeting taking place this week in San Francisco.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that effective January 3, 2011, it will begin trading on the NASDAQ Global Select Market. The NASDAQ Global Select Market is the highest NASDAQ listing tier based on financial and liquidity criteria. Prior to the effectiveness of this change in the New Year, shares of Spectrum Pharmaceuticals will continue to be traded on the NASDAQ Global Market.
NanoBio Corporation announced today that its CEO and Founder, James R. Baker, Jr., M.D., will present new data from studies of its nanoemulsion-based adjuvant platform during the World Influenza Congress, taking place from December 7-9, 2009 in Brussels, Belgium.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
› Verified 4 days ago